Evaluation of virucidal activity and preservatives
Intended
learning objectives
At the end of this lecture, the student will be able to:
• List the methods for determination of virucidal activity
of disinfectants
• Explain the methods for the determination of virucidal
activity
• Describe the challenge test for evaluation of
preservatives
Evaluation
of Virucidal Activity
• The testing of disinfectants for virucidal activity is not
easy
• Viruses are obligate intracellular parasites and are
unable in artificial culture media to grow
• They require some other system employing living cells
Suggested test viruses include
• Rotavirus, adenovirus, poliovirus, herpes simplex viruses,
human immunodeficiency virus, pox viruses and papovavirus
• Appropriate facilities for handling such pathogens are
essential
• The virus is grown in an appropriate cell line that is
then mixed with water containing an organic load and the disinfectant under
test
• After appropriate time, residual viral infectivity is
determined using a
• Tissue
culture/plaque assay
• Other
system (e.g. animal host, molecular assay for some specific viral component)
• Tissue
culture or egg inoculation
•
Bacteriophage evaluation method
• Plaque
assays
• Duck hepatitis
B virus (DHVB) method
• Acceptable
animal model
• A reduction of infectivity by a factor of 104 has been
regarded as evidence of acceptable virucidal activity
• For viruses which cannot be grown in the laboratory (e.g.
hepatitis B), naturally infected cells/tissues must be used
Limitations
• Such procedures are costly
• Time-consuming
• Must be appropriately controlled to exclude factors such
as disinfectant killing of the cell system or test animal
Evaluation
of Preservatives
• Preservatives are widely employed in the cosmetic and
pharmaceutical industries as well as in a variety of other manufacturing
industries
• The inhibitory or bactericidal activity of the chemical to
be used as the preservative can be evaluated using an appropriate in vitro test
system
• Its continued activity when combined with the other
ingredients in the final manufactured product must be established
Evaluation of
Preservatives – Challenge test
• The final preserved product is deliberately inoculated
with a suitable environmental microorganism
• Fungal, e.g.
candida, or bacterial,
e.g. Staphylococcus aureus, Escherichia coli, Pseudomonas
aeruginosa
• For preparations with a high sucrose content, the
osmophilic yeast Zygosaccharomyces rouxii is a consideration
• The subsequent survival (inhibition), death or growth of
the inoculum is then assessed using viable count techniques
Evaluation
of Mycobactericidal activity
• They are hydrophobic in nature, hence difficult to prepare
homogeneous suspensions of mycobacteria
• M.tuberculosis are slow growing pathogenic strains hence a
non- pathogenic M.terrae is used as an indicator organism
• General bacteriostatic and bactericidal evaluations are
carried out
Evaluation
of Sporicidal activity
• Sporicidal activity can be determined against spores in
liquid suspension or against spores dried on carriers
• General bacteriostatic and bactericidal evaluations are
carried out
• Since they are spores, sufficient germination time must be
given considering that damaged spores require even more time for germination
Evaluation
of Antifungal activity
• Fungi may be potential pathogens, which occurs as contaminants
in pharmaceutical products
• Fungicidal activity – general procedure, suitable culture
media
• Fungitatic activity – Solid dilution test Liquid dilution
test Gradient – plate technique
Summery
Sl. No. | Evaluation of | Method |
1 | Virucidal | • The test virus us exposed to virucidal • Residual viral infectivity is determined suitable |
2 | Solid | • Dusting the powders onto the surface of agar • Extent of growth is then observed following incubation |
3 | Air Disinfectant | • Bacterial or fungal airborne ‘suspensions’ closed • Exposed to the disinfectant • Airborne microbial population is then intervals |
4 | Preservative | • Challenge test • Final preserved product is deliberately suitable • subsequent survival (inhibition), death or inoculum |